Vessel hits probability against dose in Figure S1 -Visual flow chart for simulations.
Supplementary figures
This flow chart illustrates how cell death and cell division is implemented in the model with respect to time iteration and radiation exposure.
Figure S2 -Comparison of 2D tumour growth corrected to represent volume with 3D tumour growth model
In the 3D tumour growth model, the tumour is represented as a sphere in a 3D isotropic stack over time. We then take advantage of the same algorithm by simply applying image processing in 3D (both dilation and erosion), as explained in the tumour growth model. The results were equivalent to the volume approximation from 2D simulation with the volume estimation from the 2D surface. The 2D simulations are preferred for the sake of simplicity of visualization as well as computing time and memory. Data from the literature are the same as in Fig. 1D 10-12,15
.
Figure S3: Vessel density in mice tumours
Vessel density was measured on pseudo-confocal images by quantifying the area ratio of tumourassociated blood vessels (CD31+) on 15 tumours from 15 mice, with 2 independent cohorts of mice as non-irradiated controls, as described in
5
. The measured average value of vessel density was 3.8 %. Figure S4 : HRF fit.
The Howard-Flanders model is used to fit the HRF, allowing a hypoxia reduction factor (HRF) to be modelled, which was then used to compute the dose equivalent for cell death at each specific oxygenation condition. The dose equivalent for cell death in vitro at ambient oxygen, i.e. 21%, was the dose at current oxygen level divided by HRF. The lower the O2 level (hypoxia), the greater the HRF, and therefore the lower the estimated rate of cell death. Figure S6: Competition between perfusion and vessel cell death for hypoxic levels in tumour.
At high dose (15 Gy), the effect of vessel death as a correction to perfusion hits is more obvious than, say, at 8Gy, and hypoxia dominates the perfusion effect. Note that the error bar does not take into account the fact that most tumours are completely killed at high dose without vessel death, due to less hypoxia, and therefore less tumour resistance.
